Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21

• Eric S. Muise ,

  Contributed equally to this work with: Eric S. Muise, Sandra Souza

  * E-mail: eric_muise@merck.com

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Sandra Souza ,

  Contributed equally to this work with: Eric S. Muise, Sandra Souza

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• An Chi,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Yejun Tan,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Xuemei Zhao,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Franklin Liu,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Qing Dallas-yang,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Margaret Wu,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Tim Sarr,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Lan Zhu,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Hongbo Guo,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Zhihua Li,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Wenyu Li,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Weiwen Hu,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Guoqiang Jiang,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Cloud P. Paweletz,

  Current address: Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Ronald C. Hendrickson,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• John R. Thompson,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• James Mu,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• Joel P. Berger,

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
•  [ ... ],
• Huseyin Mehmet

  Affiliation Discovery and Preclinical Sciences, Merck Research Laboratories, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, United States of America

  ⨯
• [ view all ]
• [ view less ]